invIOs to present at upcoming industry and investor conferences
VIENNA, Austria, Oct. 11, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH (invIOs), a privately held biotechnology company developing novel therapies for cancer, today announces its participation at three upcoming industry and investor conferences: BIO-Europe, Inv$tival Showcase and the Jefferies 2022 London Healthcare Conference.
- VIENNA, Austria, Oct. 11, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH (invIOs), a privately held biotechnology company developing novel therapies for cancer, today announces its participation at three upcoming industry and investor conferences: BIO-Europe, Inv$tival Showcase and the Jefferies 2022 London Healthcare Conference.
- A digital company presentation by Peter Llewellyn-Davies is available now online via the event partnering system.
- Peter Llewellyn-Davies will present invIOss cell therapy platform, EPiC, and pipeline of clinical and pre-clinical assets on the Biotech Late Growth Stage.
- invIOs is a privately held biotech company based in Vienna, Austria, focusing on the discovery and development of innovative cancer immunotherapies.